Literature DB >> 16799707

HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia?

Amal Baccar Harrath1, Besma Yacoubi Loueslati, Wafa Troudi, Slama Hmida, Syrine Sedkaoui, Amel Dridi, Afef Jridi, Farhat Ben Ayed, Khaled Ben Rhomdhane, Amel Ben Ammar Elgaaied.   

Abstract

HLA system plays a key role in the tumor cells' escape from immune surveillance. Herein is the first report on the correlation of the susceptibility to breast cancer with HLA class II markers in Tunisia. Molecular typing of HLA-DRB1 and -DQB1 loci was undertaken for 70 Tunisian female patients. Comparison of allele and haplotype distribution between patients and 70 female control subjects reveals a negative association between HLADRB1* 07-DQB1*02 and the incidence of breast cancer in the Tunisian population.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16799707     DOI： 10.1007/bf02893448

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


  24 in total

1.  Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.

Authors:  S Chaudhuri; A Cariappa; M Tang; D Bell; D A Haber; K J Isselbacher; D Finkelstein; D Forcione; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

Review 3.  Death and anti-death: tumour resistance to apoptosis.

Authors:  Frederik H Igney; Peter H Krammer
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

4.  Serological and molecular study on the HLA phenotype of female breast cancer patients.

Authors:  C Casoli; P Zanelli; A Adorni; B R Starcich; T Neri
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  Cloning of the HLA class II region in yeast artificial chromosomes.

Authors:  J Ragoussis; A Monaco; I Mockridge; E Kendall; R D Campbell; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  Breast cancer and histocompatibility antigens.

Authors:  M L Subirá; C D Crisci; G Zornoza; M L Sanz; J Voltas; J L Hernández; A Oehling
Journal:  Allergol Immunopathol (Madr)       Date:  1979 Nov-Dec       Impact factor: 1.667

7.  The HLA class III subregion is responsible for an increased breast cancer risk.

Authors:  Mirjam M de Jong; Ilja M Nolte; Elisabeth G E de Vries; Michael Schaapveld; Jan H Kleibeuker; Elvira Oosterom; Jan C Oosterwijk; Annemarie H van der Hout; Gerrit van der Steege; Marcel Bruinenberg; H Marike Boezen; Gerard J Te Meerman; Winette T A van der Graaf
Journal:  Hum Mol Genet       Date:  2003-07-22       Impact factor: 6.150

8.  HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.

Authors:  R J Apple; H A Erlich; W Klitz; M M Manos; T M Becker; C M Wheeler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

9.  Human leucocytic antigens (HLA) in breast cancer.

Authors:  B M Biswal; R Kumar; P K Julka; U Sharma; M C Vaidya
Journal:  Indian J Med Sci       Date:  1998-05

10.  HLA antigens in malignant melanoma patients.

Authors:  G Pellegris; M T Illeni; M Vaglini; D Rovini; N Cascinelli; C Masserini
Journal:  Tumori       Date:  1980-02
View more
  9 in total

1.  Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis.

Authors:  Yong-Ning Xin; Zhong-Hua Lin; Xiang-Jun Jiang; Shu-Hui Zhan; Quan-Jiang Dong; Qing Wang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.

Authors:  Majid Mahmoodi; Hedayat Nahvi; Mahdi Mahmoudi; Amir Kasaian; Mohammad-Ali Mohagheghi; Kouros Divsalar; Bijan Nahavandian; Abbas Jafari; Bita Ansarpour; Batoul Moradi; Asghar Aghamohammadi; Aliakbar Amirzargar
Journal:  Pathol Oncol Res       Date:  2011-07-01       Impact factor: 3.201

3.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

Review 4.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

5.  Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis.

Authors:  Linlin Liu; Xu Sun; Chenxi Yuan; Huaimin Liu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

6.  Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas.

Authors:  Quan Zhou; Jin Xu; Jiali Zhao; Shaoxian Zhang; Wei Pan
Journal:  Onco Targets Ther       Date:  2014-03-24       Impact factor: 4.147

7.  Association between DLA-DRB1.2 allelic diversity and development of mammary gland tumors in dogs.

Authors:  Seyed Milad Vahedi; Gholamreza Nikbakht; Shahram Jamshidi; Leila Lankarani; Nika Alimi; Atefeh Esmailnejad
Journal:  Acta Vet Scand       Date:  2019-11-14       Impact factor: 1.695

Review 8.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

9.  High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.

Authors:  David Cantú de León; Delia Pérez-Montiel; Verónica Villavicencio; Alejandro García Carranca; Alejandro Mohar Betancourt; Victor Acuña-Alonzo; Alberto López-Tello; Gilberto Vargas-Alarcón; Rodrigo Barquera; Neng Yu; Edmond J Yunis; Julio Granados
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.